Cardiovascular diseases particularly ischaemic heart disease is one of the main causes of morbidity and mortality. Most predisposing factors for a vascular disease have a silent course and commonly coexist in one individual, producing synergistic deleterious effects. Early determination and treatment of modifiable risk factors could prevent irreversible damage to the heart and other vasculature. 6 Only recently prevalence of this syndrome in patients with acute coronary syndrome is being studied. The prevalence of MS is high (46%) in acute myocardial infarction (AMI) patients. 7 Patients with acute MI, with or without MS, treated with primary PCI showed that MS patients had large infarct size, more in hospital complications and a marked increase of acute renal failure. 8 A study conducted by Momen A. showed that patients of acute ST elevation myocardial infarction with MS have poor in hospital outcome than those without MS. 9 A small population based study conducted by Zaman and colleagues showed the prevalence of MS in women (>45 years) of Bangladesh is 6.2 %. 10 Jamil AA showed that patients with MS having CHD have higher triple vessel disease, increased totally occlusive lesions and more extensive and diffuse disease as compared to those without MS. 11 The pathogenesis of MS is multifactorial. The major underlying risk factors are insulin resistance and obesity. Several factors exacerbate the syndrome. Physical inactivity, advancing age, endocrine dysfunction and genetic aberrations affect individual risk factors. The increasing prevalence of MS in the US and worldwide, however, seems to be driven largely by more obesity exacerbated by sedentary lifestyles. In patients with MS, relative risk for atherosclerotic coronary vascular disease (ASCVD) ranges from 1.5 to 3 when diabetes not yet present, risk for progression to Type II diabetes averages about five fold increase, compared with those without the syndrome. 12 ASCVD risk in MS is greater than the sum of its measured risk factors as evident from epidemiological studies and the risk rises geometrically instead of linearly. 12 Prevalence of MS varies with age and sex. In the USA the prevalence is 7% in participants aged 20-29 years and 44% in aged 60-69 years. 13 
Methods
This cross sectional study was conducted in the department of cardiology, Dhaka Medical College Hospital, Dhaka, Bangladesh from January 2010 to December 2010 to compare the in-hospital outcome of Acute Coronary Syndrome (ACS) patients with or without metabolic syndrome (MS). Acute coronary syndrome patients presenting first time in the hospital who are fulfilling the NCEP-ATPIII definition of metabolic syndrome were included as study population and exclude those patients having previous history of myocardial infarction (STEMI, Non-STEMI) / unstable angina / PCI / CABG; patients having heart failure, cardiomyopathy, congenital heart disease, valvular heart disease and other severe co-morbid conditions (eg. Septicemia, renal and hepatic impairment).Total 210 ACS patients were included in this study and divided into two groups; group I & II on the basis of presence or absence of MS respectively. Data was collected through: Interviewing, Clinical examination &Laboratory investigation.Data was analyzed by using SPSS (Statistical package for social sciences) version 11.5 .Test statistics used to analyze the data were descriptive statistics, Chi square and unpaired t-Test. Level of significance was set at 0.05.
Result and observations
Study showed that in group I maximum patients (36.4%) belong to age group of 41 to 50 years. On the other hand in group II maximum (31%) belong to age group of 41 to 50 years. Mean ± SD of age in group I and group II was 52.99 ± 11.49 years and 53.34 ± 12.54 years respectively ( Table-I) . 70% were male and 30% were female in group I. In group II 70% were male and 30% were female. There was no statistical difference between two groups. Lentzas et al. (2007) 16 showed the mean age was 67±11years and 69% of the patients were males. Prasad et al. (2008) 17 also showed the mean age was 59 (±13) years and 80% were males.
Out of all respondents in group I, 70% had hypertension, 100% had dyslipidaemia, 36.4% had hyperglycaemia, 24.5% were smoker 31.8% had family history of cardiovascular disease. On the other hand in group II 15% had hypertension, 97% had dyslipidaemia, 6% had hyperglycaemia, 30% were smoker, and 54% had family history of cardiovascular disease. Hypertension, diabetes mellitus, family history of cardiovascular disease were statistically significant between two groups. (p value < 0.05). Also the use of antihypertensive drugs (17.3%% vs 0%) and lipid lowering drugs (3.6%vs 0%) were significantly different between two groups.
The present study is comparable with some other series. In the study of Gupta et al. (2009) 18 Present study showed, in hospital outcome was poorer in group I in comparison to group II. Like 10% had cardiogenic shock, 28.2% had LVF, 5.4% had CVD, whereas in, Group II, 1% had cardiogenic shock, 16% had LVF, none had CVD. There were statistically significant difference between these results of group I and group II. In addition, absence of complication was far more in group II than in group I (52.0%vs 15.4%), which was also highly significant statistically. But there is no significant statistical difference in tachyarrhythmia (14.5% vs 14%), heart block (2o% vs 17%), cardiac arrest 21 reported incidence of metabolic syndrome among patients with an acute coronary syndrome varied between 29% and 46%. Patients with metabolic syndrome and acute coronary syndrome had increased incidence of heart failure, and worse long-term mortality compared to those without metabolic syndrome. Perron and Sweeney (2005) 22 described, nearly 90% of patients who experienced acute myocardial infarction (AMI) developed some cardiac rhythm abnormality and 25% had a cardiac conduction disturbance within 24 h ours of infarct onset.
Conclusion:
The metabolic syndrome in subjects with cardiovascular diseases occurs considerably more often than in general population. The most frequently occurring features of metabolic syndrome in subjects with cardiovascular diseases are: obesity, hypertension, hypertriglyceridemia and hyperglycaemia. As the presence of MS in patients suffered from ACS was associated with a higher incidence of cardiovascular complications and mortality so, early diagnosis and proper treatment of the metabolic syndrome is needed in reducing incidence and in secondary prevention of cardiovascular diseases.
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